With a quarterly dividend of $0.27 a share -- or $1.08 a year -- it would take 926 shares of Sirius XM for you to generate $1,000 in annual distributions. This would be a roughly $26,000 stake at ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Anyone can code using AI. But it might come with a hidden cost. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Over the past year, AI systems have ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Fans were gripping fences all Sunday morning as the sounds of racecars serenaded the tens of thousands who flocked to IndyCar’s inaugural Java House Grand Prix of Arlington. Kyle Kirkwood won the race ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...